- Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient
-
Perrone S, Barbera EOL, Ottone T, Capriata M, Passucci M, Filippi L, Bagni O, Voso MT, Cimino G
- KMID: 2507744
- Nucl Med Mol Imaging.
- 2020 Oct;54(5):256-260.
- doi: 10.1007/s13139-020-00652-9
223Ra-dichloride is a bone-seeking targeted alpha (α)-emitting approved for bone metastases in prostate cancer. Here, we report a case of therapy-related acute promyelocytic leukemia (t-APL) following administration of 223Ra, showing... -
- CITED
-
- Close
- SHARE
-
- Close
